Huami has every intention of becoming a major brand in the field of physical and health monitoring, with its products. Amazfit and Zepp. The manufacturer from Xiaomi has renamed itself Zepp Health outside the Chinese market, and it intends to attack the American market. First step in this conquest: get the green light from the FDA for the ECG app for Amazfit watches.
The Food and Drug Administration, the federal health authority that authorizes the marketing of new drugs, usually takes its time before certifying a device – which is understandable given the health implications. Apple has had proof of this with the Apple Watch Series 4 which snatched FDA clearance 24 hours before the watch was presented.
Zepp Health hopes to speed up the process through an agreement with Alivecor, whose Kardia Band bracelet had been approved by the FDA in 2016. The Chinese manufacturer will simply use Alivecor’s algorithm in its products. Theoretically, ” this should speed up the approval », hope Mike Yeung, the chief operating officer of Zepp Health. Who recalls having obtained the certification of the Chinese equivalent of the FDA for the ECG of the Health Band bracelet 18 months before Apple!
And Zepp Health does not want to stop there. The company is working on a sensor to measure blood pressure and a blood glucose meter (a priori) non-invasive, the latter representing a kind of holy grail for many manufacturers (read: Apple and Samsung are working on a blood glucose meter for their watches from 2021). Yeung is optimistic even if he does not hide the difficulty of this development.
Zepp Health, which is definitely not lacking in projects, also wants to adapt its software ecosystem to the American market, which requires the support of Spotify and a compatible payment system.
– .